Carregant...

The effectiveness of retreatment with peginterferon alfa and ribavirin in patients with chronic viral hepatitis C genotype 2 and 3: a prospective cohort study in Brazil

BACKGROUND: More than 50% of patients infected with chronic hepatitis C virus (HCV) do not respond to treatment with conventional interferon (IFN) combined with ribavirin (RBV). The aim of our study was to evaluate the effectiveness of retreatment with peginterferon alfa-2a or 2b (PEG-IFN 2a or 2b)...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Artico, Simara, Amaral, Karine Medeiros, Gonçalves, Candice Beatriz Treter, Picon, Paulo Dornelles
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2012
Matèries:
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3548710/
https://ncbi.nlm.nih.gov/pubmed/23270376
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2334-12-377
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!